Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Summary

The primary efficacy endpoint for this study is the proportion of subjects with complete closure of Target Ulcer during the 20-week Treatment Phase, which is assessed by the blinded independent evaluator.

Timeline

Start

2021-07-27

Primary completion

2022-11-01

Completion

2022-11-29

Outcome

Outcome not reported

Stopped (Business): “Due to the product development strategy adjustment, the Sponsor terminated this study.”

Drugs

Indications